The opioid receptor triple agonist DPI-125 produces analgesia with less respiratory depression and reduced abuse liability-Reference-Cited by-同舟云学术

The opioid receptor triple agonist DPI-125 produces analgesia with less respiratory depression and reduced abuse liability

Published:2017-05-15 Issue:7 Volume:38 Page:977-989
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Yi Shou-pu,Kong Qing-hong,Li Yu-lei,Pan Chen-ling,Yu Jie,Cui Ben-qiang,Wang Ying-fei,Wang Guan-lin,Zhou Pei-lan,Wang Li-li,Gong Ze-hui,Su Rui-bin,Shen Yue-hai,Yu Gang,Chang Kwen-jen

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.nature.com/articles/aps201714.pdf

Reference65 articles.

1. Granier S, Manglik A, Kruse AC, Kobilka TS, Thian FS, Weis WI, Kobilka BK . Structure of the delta-opioid receptor bound to naltrindole. Nature 2012; 485: 400–4.

2. Manglik A, Kruse AC, Kobilka TS, Thian FS, Mathiesen JM, Sunahara RK, et al. Crystal structure of the micro-opioid receptor bound to a morphinan antagonist. Nature 2012; 485: 321–6.

3. Thompson AA, Liu W, Chun E, Katritch V, Wu H, Vardy E, et al. Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic. Nature 2012; 485: 395–9.

4. Wu H, Wacker D, Mileni M, Katritch V, Han GW, Vardy E, et al. Structure of the human kappa-opioid receptor in complex with JDTic. Nature 2012; 485: 327–32.

5. Fenalti G, Giguere PM, Katritch V, Huang XP, Thompson AA, Cherezov V, et al. Molecular control of delta-opioid receptor signalling. Nature 2014; 506: 191–6.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in attenuating opioid-induced respiratory depression: A narrative review;Medicine;2024-07-19

2. An Overview of Recent Developments in the Management of Burn Injuries;International Journal of Molecular Sciences;2023-11-15

3. Opioids and opioid receptors; understanding pharmacological mechanisms as a key to therapeutic advances and mitigation of the misuse crisis;BJA Open;2023-06

4. Oral Oxycodone‐Induced Respiratory Depression During Normocapnia and Hypercapnia: A Pharmacokinetic‐Pharmacodynamic Modeling Study;Clinical Pharmacology & Therapeutics;2023-02-22

5. Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid Receptors;Pharmaceuticals;2022-07-15